---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-038093"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T06:02:54.190395+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Hiroshi Nomura resigns from Roivant board effective Aug 31, 2023

## Summary
- Hiroshi Nomura, Class III director, to resign from board effective August 31, 2023.
- Resignation is to focus on other business affairs; no disagreement with company.
- No replacement named; board size reduces.

## SEC filing metadata
- accession: 0001140361-23-038093
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000114036123038093/0001140361-23-038093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000114036123038093/brhc20057013_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-038093
- JSON: https://secwatch.observer/filing/0001140361-23-038093.json
- Plain text: https://secwatch.observer/filing/0001140361-23-038093.txt

## Key facts
- Executive change
  Hiroshi Nomura resigned as Class III Director at Roivant Sciences Ltd..
  - Action: resigned
  - Role: Class III Director
  source text: On July 31, 2023, Hiroshi Nomura, a Class III director of Roivant Sciences Ltd. (the “Company”), informed the Company of his intention to resign from his role on the Company’s board of directors (the “Board”), effective August 31, 2023, to focus on other business affairs.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1635088/000114036123038093/0001140361-23-038093-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.